Public Market Listing
002262SZSE
Live quotes, historical charts, and market capitalization for Jiangsu Nhwa Pharmaceutical Co., Ltd. are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(2 total)
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
Quarterly & interim (4)
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2026-Q1 | $233M | $23M | $207M | — | report ↗ |
View 3 more
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2025-Q3 | $625M | $72M | $251M | — | report ↗ |
| 2025-H1 | $415M | $46M | $247M | — | report ↗ |
| 2025-Q1 | $208M | $26M | $287M | — | report ↗ |
Annual history (5 years)
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2025-FY | $823M | $95M | $207M | — | report ↗ |
Jiangsu Nhwa Pharmaceutical Co., Ltd. reported revenue of $822.96M, up 3.8% YoY, R&D spend of $95.44M, up 15.1% YoY, and cash and equivalents of $207.06M for fiscal year 2025.
Figures only: this period's report disclosed no narrative text